Clinical Trials Logo
  1. Home
  2. Radiation Therapy Complication
  3. NCT04549246

Grid Therapy for Tumors of the Head, Neck, Thorax, Abdomen, Pelvis and Extremities.

Radiation Therapy Complication Clinical Trial

Official title:
Spatially Fractionated Radiation (Grid) Therapy for Tumors of the Head & Neck, Thorax, Abdomen, Pelvis, and Extremities

Clinical Trial Summary

This study is an observational registry study evaluating the clinical outcomes of grid therapy. Subjects will be screened at outpatient clinic visit appointments and interested qualified subjects will be consented and offered participation in this study. Once consent has been obtained, baseline adverse event and QOL data will be collected and subjects will undergo grid therapy and follow-up at 2-4 weeks (for toxicity), and 3-6 months (for toxicities and radiographic control) then per clinical discretion up to 1 year. Patients will be evaluated according to the physician's standard practice and discretion. Patient data will be drawn from the patients' medical records and reported by means of a web-based electronic data collection (EDC) system. Patients will be considered "on study" until 60 months of observation has occurred, withdrawal of consent, lost to follow-up, or study closure. See below for the clinical visit flowchart for data collected at baseline and standard clinic visits.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04549246
Study type Observational
Source Mayo Clinic
Contact
Status Recruiting
Phase
Start date June 18, 2020
Completion date June 18, 2025
View Details
See also
  Status Clinical Trial Phase
Completed NCT04277650 - System for High-Intensity Evaluation During Radiotherapy N/A
Completed NCT03302676 - The Use of Chewing Gum for Xerostomia and Hyposalivation After Radiotherapy for Oral and Oropharyngeal Tumors N/A
Withdrawn NCT03029416 - Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension Phase 2
Recruiting NCT05907681 - Prospective Observational Study on Outcome of High-precision Hypo-fractionated Radiotherapy in Metastatic Breast Cancer (PRECISE-M)
Completed NCT04699487 - Efficacy and Safety of CareMin650 for Prevention of Oral Mucositis in HNC Patients Starting Radiotherapy N/A
Recruiting NCT04266223 - Surface Monitoring Technology to Remove The Mask - Stage 1 N/A
Completed NCT06216106 - Data Collection of Prepectoral Breast Reconstruction With Polyurethane Implantes
Completed NCT01549782 - Mixture of Prebiotics on Intestinal Microbiota of Patients Receiving Abdominal Radiotherapy. N/A
Not yet recruiting NCT02832635 - A Clinical Trial on Whole-brain Radiotherapy With Temozolomide Concurrent Chemotherapy or Avoidance of Hippocampus for Patients of Brain Metastases Phase 2
Suspended NCT02022293 - Atorvastatin in Preventing Nasopharyngeal Carcinoma Patients Receiving Radiotherapy From Carotid Stenosis Phase 2
Recruiting NCT05134558 - Xenon-enhanced Ventilation CT-guided Radiotherapy for Lung Cancer Treatment N/A
Recruiting NCT04282876 - Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer
Active, not recruiting NCT05218824 - Collection of Head Images During Radiotherapy